和黄医药为何45亿元出售“现金奶牛”?

中国经营网
17 Jan

近期, 和黄医药 (00013.HK)公告,拟作价44.78亿元出售上海和黄药业有限公司(以下简称“上海和黄药业”)45%的股权。其中,金浦健服股权投资管理有限公司拟以34.83亿元获取交易标的35%的股权,而 上海医药 (601607.SH)拟以9.95亿元收购10%股权。2001年,和黄医药与上海医药合资设立了上海和黄药业,长期以来,双方各持有合资公司50%的股份。2023年,和黄医药应占的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10